Covid Vaccines Targeting Omicron Should Be Standard, Panel Saysnews2023-01-26T22:46:39+00:00January 26th, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
Medicare Begins to Rein In Drug Costs for Older Americansnews2023-01-14T16:52:43+00:00January 14th, 2023|The New York Times|
Paxlovid para covid: ¿quién debería tomarlo?news2023-01-12T12:54:08+00:00January 12th, 2023|The New York Times|
Countries Need to Make Their Own Vaccines. Why Isn’t the U.S. Embracing This Pandemic Prevention Strategy?news2022-12-06T20:59:36+00:00December 6th, 2022|The New York Times|
How Immunocompromised Experts Will Celebrate Another Pandemic Holidaynews2022-11-22T23:39:31+00:00November 22nd, 2022|The New York Times|
The End of Covid Vaccines at ‘Warp Speed’news2022-11-18T14:02:03+00:00November 18th, 2022|The New York Times|
New Booster Shot Targets Covid Variants More Effectively, Pfizer Saysnews2022-11-04T22:39:18+00:00November 4th, 2022|The New York Times|
New Covid Variants Are Circulating. Here’s What to Know.news2022-11-04T14:33:26+00:00November 4th, 2022|The New York Times|
¿Las nuevas vacunas contra la malaria podrán erradicarla?news2022-10-08T09:00:27+00:00October 8th, 2022|The New York Times|
